Abstract:OBJECTIVE:Monitoring of minimal residual disease (MRD) is proven to be increasingly valuable for predicting relapse and outcome of childhood acute lymphoblastic leukemia (ALL) and is used to identify patients' risk groups in several current clinical trials. However, the limitation is that most studies focused on the cut-off value at 10(-4) and the time point after induction. The aim of this study was to investigate the predictive values of different MRD levels detected at different chemotherapy phases in childhood ALL. METHODS:One hundred and two patients were enrolled in this study from January 2002 to December 2004 in our hospital. All the patients were treated with modified National Protocol of Childhood ALL in China 1997. MRD levels were detected on the 15th day, 29th day, at 3 months, 6 months and 12 months after initial chemotherapy. All samples were stained with a panel of four colour combinations of fluorochrome conjugated monoclonal antibodies according to the leukemia-associated immunophenotype (LAIP) defined at diagnosis and analyzed by multi-parametric flow cytometry. CD45CD19CD34CD10, CD45CD19CD34CD20 and CD45CD19CD10CD20 were the most common combinations in B lineage ALL, while CD45CD2CD3CD7 and CD45CD2CD3CD34 were the most frequently used immunophenotypes for T lineage ALL. The median follow-up time was 63.3 months ranged from 40.6 to 87.5 months. RESULTS:Of the 102 patients, 64 were male and 38 were female, with a median age of 5.7 (0.2 - 14.8) years. Eighty-eight cases were diagnosed as B lineage ALL and the remaining 14 were T-ALL. The 5-year overall survival (OS) rate and event free survival (EFS) rate for this cohort were (86.9 +/- 3.4)% and (79.9 +/- 4.0)%, respectively. Twelve patients underwent relapse. Among the 102 patients, 14.3% had negative MRD (MRD < 10(-4)) on day 15, 43.9% on day 29, 39.1%, 39.7% and 45.6% had negative MRD at the third, sixth and twelfth month after chemotherapy. Patients who could achieve negative MRD within one year had superior outcome to the others [5-year EFS rates: (92.5 +/- 3.2)% vs. (58.3 +/- 8.6)%, P < 0.001]. The EFS for patients based on MRD levels measured at different stages of therapy were compared by Kaplan-Meier analyses. MRD was predictive of outcome at all 5 time points at a range of thresholds. The optimum threshold, selected for each time point on the basis of log rank analysis, progressively dropped from 10(-2) of day 15 [5-year EFS rates (79.8 +/- 10.3)% vs. (28.6 +/- 17.1)%, P < 0.001], to 10(-3) of day 29 [5-year EFS rates (88.3 +/- 4.9)% vs. (51.3 +/- 14.4)%, P < 0.003], to 10(-4) at 3 [5-year EFS rates (92.4 +/- 5.1)% vs. (65.5 +/- 7.5)%, P < 0.015], 6 [5-year EFS rates (96.3 +/- 3.6)% vs. (65.4 +/- 7.5)%, P < 0.003] and 12 [5-year EFS rates (100.0 +/- 0.0)% vs. (67.7 +/- 8.4)%, P < 0.002] months. And the hazard ratios for relapse and death at higher MRD level groups were 5.91 (95%CI: 1.9 - 18.9), 5.02 (95%CI: 1.5 - 16.5), 5.21 (95%CI: 1.2 - 22.9) and 11.10 (95%CI: 1.5 - 84.5) on day 15, day 29, at month 3 and month 6, respectively. And MRD >or= 10(-2) on day 15 was proven to be an independent predictor by multivariate Cox proportional-hazards regression model. CONCLUSION:Dynamic MRD detection by multi-parametric flow cytometry is highly predictive of outcome for childhood ALL, and the cut-off values at different time points were different.

THE VARIATION OF ERYTHROCYTE INDEX AND ITS SIGNIFICANCE DURING INHIBITORY STAGE OF BONE MARROW IN CHILDTEN WITH ACUTE LEUKEMIA

P773: THE ELEVATION OF RED BLOOD CELL DISTRIBUTION IS AN INDEPENDENT PROGNOSTIC FACTOR FOR JUVENILE MYELOMONOCYTIC LEUKEMIA

Effectiveness of Bacterial Infection-Related Cytokine Profile (BIRCP) Determination for Monitoring Pathogen Infections in Children with Hemopathy in the Bone Marrow Inhibition Phase.

Significance of the Research on the Relevance of Bone Marrowiron Stain and Serum Ferritin in the Diagnosis of Anemic Disease

Comparison of the Diagnostic Power Between Cytokine Pattern and Procalcitonin for Predicting Infection in Pediatric Hematology/Oncology Patients

Evaluation of Th1/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology/oncology patients by the use of cytometric bead array technology.

The application of erythrocyte and reticulocyte related indices in anemia and bone marrow transplantation

The Ratio of Absolute Lymphocyte Count at Interim of Therapy to Absolute Lymphocyte Count at Diagnosis Predicts Survival in Childhood B-lineage Acute Lymphoblastic Leukemia.

Prognostic Significance of Bone Marrow Examination During Induction Chemotherapy for B Acute Lymphoblastic Leukemia

Changes of Erythrocyte Immunity in Children with Leukemia Before and after Chemotherapy

Predictive Value of Cytokines and Procalcitonin on Infection in Children with Hematological Malignancies

Initial Frequency of CD34+/CD38 − Cells is Not Correlated with Minimal Residual Disease Level in 73 Chinese Children with B-cell Precursor Acute Lymphoblastic Leukemia

[Monitoring of Minimal Residual Disease in Children with Acute Lymphoblastic Leukemia and Its Prognostic Significance].

[Levels of Intracellular IL-6 and IFN-gamma in Children with Acute Lymphoblastic Leukemia].

Red Cell Distribution Width is a Predictor of Patients with Liver Cell Damage by EBV Infectious Mononucleosis in Children in Southeast China.

Increased MCHC*RDW-SD interaction values: indicators of neurological impairment in lead-poisoned children

Clinical value of blood related indexes in the diagnosis of bacterial infectious pneumonia in children

Utility of Blood Biomarkers to Predict Marrow Iron Stores in Children

Significance of Monitoring Reticulocyte Count During Chemotherapy for Patients with Cancer

The Prognostic Value Of The Peripheral Blood Cell Counts Changes During Induction Chemotherapy In Chinese Patients With Adult Acute Myeloid Leukemia

The mean reticulocyte volume is a valuable index in early diagnosis of cancer-related anemia